Moreover, pharmacological suppression of HIF‐1 or its target gene PDK1 may increase tumor cell oxygen consumption, thereby augmenting the efficacy of hypoxia‐specific cytotoxins [101, 102]. The gene discussed is HIF1A; the disease is neoplasm.